National type 2 diabetes prevention programme in Finland:: FIN-D2D

被引:159
作者
Saaristo, Timo
Peltonen, Markku
Keinanen-Kiukoonniemi, Sirkka
Vanhola, Mouno
Saltevo, Juha
Niskanen, Leo
Oksa, Heikki
Korpi-Hyovalti, Eeva
Tuomilehto, Jaakko
机构
[1] Finnish Diabet Assoc, FIN-33680 Tampere, Finland
[2] Natl Publ Hlth Inst, Diabet & Genet Epidemiol Unit, Helsinki, Finland
[3] Univ Oulu, Dept Publ Hlth Sci & Gen Practice, Oulu Hlth Ctr, Oulu Univ Hosp Dist,Unit Gen Practice, Oulu, Finland
[4] Laukaa Hlth Ctr, Laukaa, Finland
[5] Cent Finland Hosp Dist, Jyvaskyla, Finland
[6] No Savo Hosp Dist, Kuopio, Finland
[7] Pirkanmaa Hosp Dis, Tampere, Finland
[8] S Ostrobothnia Hosp Dis, Seinajoki, Finland
[9] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland
关键词
type; 2; diabetes; prevention; screening; intervention; life-style guidance;
D O I
10.3402/ijch.v66i2.18239
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives. Current evidence shows that type 2 diabetes (T2D) can be prevented by life-style changes and medication. To meet the menacing diabetes epidemic, there is an urgent need to translate the scientific evidence regarding prevention of T2D into daily clinical practice and public health. In Finland, a national programme for the prevention of T2D has been launched. The programme comprises 3 concurrent strategies for prevention: the population strategy, the high-risk strategy and the strategy of early diagnosis and management. The article describes the implementation strategy for the prevention programme for T2D. Methods. The implementation project, FIN-D2D, is being conducted in 5 hospital districts, covering a population of 1.5 million, during the years 2003-2007. The main actors in the FIN-D2D are primary and occupational health care providers. Results. The goals of the project are (1) to reduce the incidence and prevalence of T2D and prevalence of cardiovascular risk factor levels; (2) to identify individuals who are unaware of their T2D; (3) to generate regional and local models and programmes for the prevention of T2D; (4) to evaluate the effectiveness, feasibility and costs of the programme; and (5) to increase the awareness of T2D and its risk factors in, the population and to support the population strategy the diabetes prevention programme. The feasibility, effectiveness and costs of the programme will be evaluated according to a specific evaluation plan. Conclusions. Current research evidence shows that the type 2 diabetes can be effectively prevented in high-risk subjects by life-style changes, which include increased physical activity and weight reduction. FIN-D2D explores ways to implement these methods on a national level.
引用
收藏
页码:101 / 112
页数:12
相关论文
共 42 条
[1]  
[Anonymous], 1997, PUBL MIN SOC AFF HLT, P27
[2]  
Borch-Johnsen K, 1999, LANCET, V354, P617
[3]   Glucose tolerance and cardiovascular mortality -: Comparison of fasting and 2-hour diagnostic criteria [J].
Borch-Johnsen, K ;
Neil, A ;
Balkau, B ;
Larsen, S ;
Nissinen, A ;
Pekkanen, J ;
Tuomilehto, J ;
Jousilahti, P ;
Lindstrom, J ;
Pyörälä, M ;
Pyörälä, K ;
Eschwege, E ;
Gallus, G ;
Garancini, MP ;
Bouter, LM ;
Dekker, JM ;
Heine, RJ ;
Nijpels, HG ;
Stehouwer, CDA ;
Feskens, EJM ;
Kromhout, D ;
Peltonen, M ;
Pajak, A ;
Eriksson, J ;
Qiao, Q .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (03) :397-405
[4]   Motivational interviewing in health settings: a review [J].
Britt, E ;
Hudson, SM ;
Blampied, NM .
PATIENT EDUCATION AND COUNSELING, 2004, 53 (02) :147-155
[5]   Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women [J].
Buchanan, TA ;
Xiang, AH ;
Peters, RK ;
Kjos, SL ;
Marroquin, A ;
Goico, J ;
Ochoa, C ;
Tan, S ;
Berkowitz, K ;
Hodis, HN ;
Azen, SP .
DIABETES, 2002, 51 (09) :2796-2803
[6]   Acarbose for prevention of type 2 diabetes mellitus: the STOPNIDDM randomised trial [J].
Chiasson, JL ;
Josse, RG ;
Gomis, R ;
Hanefeld, M ;
Karasik, A ;
Laakso, M .
LANCET, 2002, 359 (9323) :2072-2077
[7]   No excess 12-year mortality in men with impaired glucose tolerance who participated in the Malmo Preventive Trial with diet and exercise [J].
Eriksson, KF ;
Lindgärde, F .
DIABETOLOGIA, 1998, 41 (09) :1010-1016
[8]  
Finnish Diabetes Association, 2001, DEV PROGR PREV CAR D
[9]  
Finnish Diabetes Association, 2003, PROGR PREV TYP 2 DIA
[10]  
Funnell M M, 1991, Diabetes Educ, V17, P37, DOI 10.1177/014572179101700108